Interestingly, overexpression of EGF receptor 2 (ERBB2, HER2) has been demonstrated in primary lung mucinous adenocarcinomas, which were characterized by KRAS activating mutations as well as very high levels of MUC5AC production [33,34]. Here, MUC5AC is linked to mucinous adenocarcinoma.